
COVID-19 has turned the world upside down with people shuttered at home, kids out of school, and the economy tanking. As the country moves toward a new normal, how will American healthcare change? The USC Schaeffer Center for Health Policy & Economics hosted a discussion between Dana Goldman, director of the Schaeffer Center, and Jay Crosson, immediate past chair of the Congressional Medicare Payment Advisory Commission (MedPAC) and an infectious disease physician. They will touch on the epidemiology of COVID-19 and what it means for America, cost consequences of the pandemic, and the impact of COVID-19 on the pharmaceutical industry. Learn more about the USC Schaeffer Center's COVID-19-related research: https://healthpolicy.usc.edu/topic/coronavirus/
Tags: covid , Covid-19 , coronavirus , doctor , pharmaceutical industry , Public Policy , economics , health policy , pharmacy , USC Price , USC Sol Price School of Public Policy , USC , schaeffer center , dana goldman phd , jay crosson md , Congressional Medicare Payment Advisory Commission , Medpac , infectious disease physician
See also:
comments